Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ, Markopoulos C, Santini D, Diel I, Di Leo A, Cameron D, Dodwell D, Smith I, Gnant M, Gray R, Harbeck N, Thurlimann B, Untch M, Cortes J, Martin M, Albert US, Conte PF, Ejlertsen B, Bergh J, Kaufmann M, Holen I. Hadji P, et al. Among authors: aapro m. Ann Oncol. 2016 Mar;27(3):379-90. doi: 10.1093/annonc/mdv617. Epub 2015 Dec 17. Ann Oncol. 2016. PMID: 26681681 Free article. Review.
Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK).
Joss RA, Bacchi M, Buser K, Kirchner V, Neuenschwander H, Orth B, Aapro MS, Thürlimann B. Joss RA, et al. Among authors: aapro ms. Ann Oncol. 1994 Mar;5(3):253-8. doi: 10.1093/oxfordjournals.annonc.a058803. Ann Oncol. 1994. PMID: 8186174 Free article. Clinical Trial.
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study.
Buser KS, Joss RA, Piquet D, Aapro MS, Cavalli F, Haefliger JM, Jungi WF, Bauer J, Obrist R, Brunner KW, et al. Buser KS, et al. Among authors: aapro ms. Ann Oncol. 1993 Jun;4(6):475-9. doi: 10.1093/oxfordjournals.annonc.a058556. Ann Oncol. 1993. PMID: 8353089 Free article. Clinical Trial.
Breast cancer.
Aapro M, Piccart M. Aapro M, et al. Crit Rev Oncol Hematol. 1998 Feb;27(2):135-7. doi: 10.1016/s1040-8428(97)10021-x. Crit Rev Oncol Hematol. 1998. PMID: 9571316 Review. No abstract available.
Evaluation of the elderly with cancer.
Aapro M, Extermann M, Repetto L. Aapro M, et al. Ann Oncol. 2000;11 Suppl 3:223-9. doi: 10.1093/annonc/11.suppl_3.223. Ann Oncol. 2000. PMID: 11079145 Free article. Review. No abstract available.
Patients' estimation of overall treatment burden: why not ask the obvious?
Bernhard J, Maibach R, Thürlimann B, Sessa C, Aapro MS; Swiss Group for Clinical Cancer Research. Bernhard J, et al. Among authors: aapro ms. J Clin Oncol. 2002 Jan 1;20(1):65-72. doi: 10.1200/JCO.2002.20.1.65. J Clin Oncol. 2002. PMID: 11773155 Clinical Trial.
545 results